The relationship of HIV treatment acceptance and adherence to psyschosocial factors among injecting drug users

P. Demas, Ellie Schoenbaum, A. E. Hirky, T. A. Wills, L. S. Doll, D. M. Hartel, R. S. Klein

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Seropositive injecting drug users (n = 135) participating in methadone maintenance treatment were assessed for HIV treatment behaviors, psychosocial adjustment, and HIV- and medication-specific attitudes and beliefs. Acceptance was associated with greater beliefs in zidovudine (ZDV) efficacy and ZDV as a source of control and hope. Higher ZDV control/hope beliefs were associated with both higher adherence and longer treatment duration. Lower adherence was associated with symptomatic disease stage, and alcohol/drug coping. Female gender and public assistance were associated with shorter duration of treatment. ZDV side effects and distrust of government HIV policy and HIV medications were not uncommon, but were not clearly associated with treatment behaviors. The results suggest that viewing HIV treatment as a source of control and hope may function as a motivator of treatment behaviors. This and other HIV-specific beliefs, gender issues, disease status, and psychosocial adjustment are important areas for further intervention and research.

Original languageEnglish (US)
Pages (from-to)283-291
Number of pages9
JournalAIDS and Behavior
Volume2
Issue number4
StatePublished - 1998

Fingerprint

Drug Users
HIV
Hope
Zidovudine
Social Adjustment
Therapeutics
Public Assistance
Methadone
Interpersonal Relations
Alcohols
Research
Pharmaceutical Preparations

Keywords

  • Adherence
  • Compliance
  • HIV

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Public Health, Environmental and Occupational Health

Cite this

Demas, P., Schoenbaum, E., Hirky, A. E., Wills, T. A., Doll, L. S., Hartel, D. M., & Klein, R. S. (1998). The relationship of HIV treatment acceptance and adherence to psyschosocial factors among injecting drug users. AIDS and Behavior, 2(4), 283-291.

The relationship of HIV treatment acceptance and adherence to psyschosocial factors among injecting drug users. / Demas, P.; Schoenbaum, Ellie; Hirky, A. E.; Wills, T. A.; Doll, L. S.; Hartel, D. M.; Klein, R. S.

In: AIDS and Behavior, Vol. 2, No. 4, 1998, p. 283-291.

Research output: Contribution to journalArticle

Demas, P, Schoenbaum, E, Hirky, AE, Wills, TA, Doll, LS, Hartel, DM & Klein, RS 1998, 'The relationship of HIV treatment acceptance and adherence to psyschosocial factors among injecting drug users', AIDS and Behavior, vol. 2, no. 4, pp. 283-291.
Demas, P. ; Schoenbaum, Ellie ; Hirky, A. E. ; Wills, T. A. ; Doll, L. S. ; Hartel, D. M. ; Klein, R. S. / The relationship of HIV treatment acceptance and adherence to psyschosocial factors among injecting drug users. In: AIDS and Behavior. 1998 ; Vol. 2, No. 4. pp. 283-291.
@article{b4ae443557fe4b4ab55a9454d389e5fa,
title = "The relationship of HIV treatment acceptance and adherence to psyschosocial factors among injecting drug users",
abstract = "Seropositive injecting drug users (n = 135) participating in methadone maintenance treatment were assessed for HIV treatment behaviors, psychosocial adjustment, and HIV- and medication-specific attitudes and beliefs. Acceptance was associated with greater beliefs in zidovudine (ZDV) efficacy and ZDV as a source of control and hope. Higher ZDV control/hope beliefs were associated with both higher adherence and longer treatment duration. Lower adherence was associated with symptomatic disease stage, and alcohol/drug coping. Female gender and public assistance were associated with shorter duration of treatment. ZDV side effects and distrust of government HIV policy and HIV medications were not uncommon, but were not clearly associated with treatment behaviors. The results suggest that viewing HIV treatment as a source of control and hope may function as a motivator of treatment behaviors. This and other HIV-specific beliefs, gender issues, disease status, and psychosocial adjustment are important areas for further intervention and research.",
keywords = "Adherence, Compliance, HIV",
author = "P. Demas and Ellie Schoenbaum and Hirky, {A. E.} and Wills, {T. A.} and Doll, {L. S.} and Hartel, {D. M.} and Klein, {R. S.}",
year = "1998",
language = "English (US)",
volume = "2",
pages = "283--291",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - The relationship of HIV treatment acceptance and adherence to psyschosocial factors among injecting drug users

AU - Demas, P.

AU - Schoenbaum, Ellie

AU - Hirky, A. E.

AU - Wills, T. A.

AU - Doll, L. S.

AU - Hartel, D. M.

AU - Klein, R. S.

PY - 1998

Y1 - 1998

N2 - Seropositive injecting drug users (n = 135) participating in methadone maintenance treatment were assessed for HIV treatment behaviors, psychosocial adjustment, and HIV- and medication-specific attitudes and beliefs. Acceptance was associated with greater beliefs in zidovudine (ZDV) efficacy and ZDV as a source of control and hope. Higher ZDV control/hope beliefs were associated with both higher adherence and longer treatment duration. Lower adherence was associated with symptomatic disease stage, and alcohol/drug coping. Female gender and public assistance were associated with shorter duration of treatment. ZDV side effects and distrust of government HIV policy and HIV medications were not uncommon, but were not clearly associated with treatment behaviors. The results suggest that viewing HIV treatment as a source of control and hope may function as a motivator of treatment behaviors. This and other HIV-specific beliefs, gender issues, disease status, and psychosocial adjustment are important areas for further intervention and research.

AB - Seropositive injecting drug users (n = 135) participating in methadone maintenance treatment were assessed for HIV treatment behaviors, psychosocial adjustment, and HIV- and medication-specific attitudes and beliefs. Acceptance was associated with greater beliefs in zidovudine (ZDV) efficacy and ZDV as a source of control and hope. Higher ZDV control/hope beliefs were associated with both higher adherence and longer treatment duration. Lower adherence was associated with symptomatic disease stage, and alcohol/drug coping. Female gender and public assistance were associated with shorter duration of treatment. ZDV side effects and distrust of government HIV policy and HIV medications were not uncommon, but were not clearly associated with treatment behaviors. The results suggest that viewing HIV treatment as a source of control and hope may function as a motivator of treatment behaviors. This and other HIV-specific beliefs, gender issues, disease status, and psychosocial adjustment are important areas for further intervention and research.

KW - Adherence

KW - Compliance

KW - HIV

UR - http://www.scopus.com/inward/record.url?scp=0031697511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031697511&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031697511

VL - 2

SP - 283

EP - 291

JO - AIDS and Behavior

JF - AIDS and Behavior

SN - 1090-7165

IS - 4

ER -